Back to Search
DENNIS SLAMON, MD
MD
Hematology & Oncology Physician
NPI: 1932129533IndividualAccepts Medicare
Specialties, Licenses & Credentials
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
G39056(CA)
CMS Specialties
PrimaryHEMATOLOGY/ONCOLOGY
Education
UNIVERSITY OF ILLINOIS COLLEGE OF MED (CHI/PEOR/ROCK/CHM-URB)
Class of 1975
Research & Publications (20)
The FUTURE of ErbB-1 and ErbB-2 pathway inhibition in breast cancer: targeting multiple receptors.
PMID 15163840·Oncologist·2004
8-other
Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.
PMID 11248153·N Engl J Med·2001
3-trial
Rationale for trastuzumab (Herceptin) in adjuvant breast cancer trials.
PMID 11301370·Semin Oncol·2001
6-review
Herceptin: increasing survival in metastatic breast cancer.
PMID 12849614·Eur J Oncol Nurs·2000
8-other
CpG island methylation affects accessibility of the proximal BRCA1 promoter to transcription factors.
PMID 19466541·Breast Cancer Res Treat·2010
4-observational
Guidelines for human epidermal growth factor receptor 2 testing: biologic and methodologic considerations.
PMID 19204209·J Clin Oncol·2009
6-review
A phase I/II trial of trastuzumab plus erlotinib in metastatic HER2-positive breast cancer: a dual ErbB targeted approach.
PMID 19299235·Clin Breast Cancer·2009
3-trial
Alterations in the TOP2A and HER2 genes: association with adjuvant anthracycline sensitivity in human breast cancers.
PMID 19401550·J Natl Cancer Inst·2009
8-other
In vitro metabolism of the specific endothelin-A receptor antagonist ZD4054 and clinical drug interactions between ZD4054 and rifampicin or itraconazole in healthy male volunteers.
PMID 19480550·Xenobiotica·2009
3-trial
Frequent activating mutations of PIK3CA in ovarian clear cell carcinoma.
PMID 19349352·Am J Pathol·2009
4-observational
Clinical significance of Akt and HER2/neu overexpression in African-American and Latina women with breast cancer.
PMID 18184439·Breast Cancer Res·2008
8-other
Activity of lapatinib a novel HER2 and EGFR dual kinase inhibitor in human endometrial cancer cells.
PMID 18334972·Br J Cancer·2008
8-other
Promoter methylation study of the H37/RBM5 tumor suppressor gene from the 3p21.3 human lung cancer tumor suppressor locus.
PMID 18038152·Hum Genet·2008
8-other
Comprehensive analysis of 20q13 genes in ovarian cancer identifies ADRM1 as amplification target.
PMID 18615678·Genes Chromosomes Cancer·2008
8-other
Inhibitors of protein geranylgeranyltransferase I and Rab geranylgeranyltransferase identified from a library of allenoate-derived compounds.
PMID 18230616·J Biol Chem·2008
7-preclinical
A phase I and pharmacokinetic study of sunitinib administered daily for 2 weeks, followed by a 1-week off period.
PMID 17505827·Cancer Chemother Pharmacol·2008
3-trial
In vitro metabolism of a triclyclic alkaloid (M445526) in human liver microsomes and hepatocytes.
PMID 17896324·Xenobiotica·2007
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 200 MEDICAL PLAZA, #365,530,420,120
LOS ANGELES, CA 90095 - Phone
- (310) 825-5193
Quick Facts
- NPI
- 1932129533
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 51
- Publications
- 20
Are you this provider?
Claim Your Profile